CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 2014—Definiens received the 2013 Global Frost & Sullivan Award for Company of the Year for Global Tissue Diagnostics and Pathology Imaging Solutions.
Definiens Tissue Studio and Definiens Image Miner have set industry benchmarks with their capabilities to deliver best-in-class image interpretation and data mining, according to a statement from Frost & Sullivan. This enables the morphological features of tissue slides to be quantitated rapidly, a process Definiens refers to as tissue datafication.
The reason for Definiens’ leading position in the area of tissue datafication lies in its patented Definiens Cognition Network Technology, which mimics the human mind’s cognitive powers to reposition knowledge within a semantic network. This technology, invented by Nobel Prize winner Gerd Binnig, PhD, is able to understand and analyze image features in the context of their surroundings. Due to its ability to accelerate cellular biomarker screening and translational research, Definiens’ technology will be a game changer in the drug discovery process, Frost & Sullivan reported.
Definiens, 760-893-8900